ResearcherUniversity of Missouri–Kansas CityActive in the last 2 years
Kun Cheng
Matched on ORCID iD 0000-0001-9544-4680; OpenAlex author ID A5066607484. Sources: OpenAlex.
Their work
- Papers
- 7 (first author 0, last author 4)
- Trials
- 0
- Grants
- 0
- Labs led
- 1
- Collaborators
- 15
2019: 1 paper · 2020: none · 2021: 2 papers · 2022: none · 2023: 1 paper · 2024: 1 paper · 2025: 2 papers
Papers 7
- Small extracellular vesicles (sEVs) in pancreatic cancer progression and diagnosis. Last author DOI 10.1016/j.jconrel.2025.01.072↗
- Mechanistic and functional characterization of ABTB2 as a novel target for pancreatic cancer therapy. Co-author DOI 10.1016/j.omton.2025.201080↗
- Delivery of a STING Agonist Using Lipid Nanoparticles Inhibits Pancreatic Cancer Growth. Last author DOI 10.2147/ijn.s462213↗
- A novel role of TGFBI in macrophage polarization and macrophage-induced pancreatic cancer growth and therapeutic resistance. Co-author DOI 10.1016/j.canlet.2023.216457↗
- LMO7 as an Unrecognized Factor Promoting Pancreatic Cancer Progression and Metastasis. Co-author DOI 10.3389/fcell.2021.647387↗
- Silencing PCBP2 normalizes desmoplastic stroma and improves the antitumor activity of chemotherapy in pancreatic cancer. Last author DOI 10.7150/thno.53102↗
- Development of a Tumor-Responsive Nanopolyplex Targeting Pancreatic Cancer Cells and Stroma. Last author DOI 10.1021/acsami.9b15116↗
Closest collaborators
The 15 strongest of 15 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Guangfu Li · 4 shared papers, 2021–2025 · strength 0.68
- Paper Mechanistic and functional characterization of ABTB2 as a novel target for pancreatic cancer therapy. DOI 10.1016/j.omton.2025.201080↗
- Paper A novel role of TGFBI in macrophage polarization and macrophage-induced pancreatic cancer growth and therapeutic resist… DOI 10.1016/j.canlet.2023.216457↗
- Paper Silencing PCBP2 normalizes desmoplastic stroma and improves the antitumor activity of chemotherapy in pancreatic cancer. DOI 10.7150/thno.53102↗
- Yuanke Li · 3 shared papers, 2019–2025 · strength 0.56
- Paper Small extracellular vesicles (sEVs) in pancreatic cancer progression and diagnosis. DOI 10.1016/j.jconrel.2025.01.072↗
- Paper Silencing PCBP2 normalizes desmoplastic stroma and improves the antitumor activity of chemotherapy in pancreatic cancer. DOI 10.7150/thno.53102↗
- Paper Development of a Tumor-Responsive Nanopolyplex Targeting Pancreatic Cancer Cells and Stroma. DOI 10.1021/acsami.9b15116↗
- Eric T. Kimchi · 3 shared papers, 2021–2025 · strength 0.53
- Paper Mechanistic and functional characterization of ABTB2 as a novel target for pancreatic cancer therapy. DOI 10.1016/j.omton.2025.201080↗
- Paper A novel role of TGFBI in macrophage polarization and macrophage-induced pancreatic cancer growth and therapeutic resist… DOI 10.1016/j.canlet.2023.216457↗
- Paper LMO7 as an Unrecognized Factor Promoting Pancreatic Cancer Progression and Metastasis. DOI 10.3389/fcell.2021.647387↗
- Nan Lyu · 2 shared papers, 2023–2025 · strength 0.41
- Paper Mechanistic and functional characterization of ABTB2 as a novel target for pancreatic cancer therapy. DOI 10.1016/j.omton.2025.201080↗
- Paper A novel role of TGFBI in macrophage polarization and macrophage-induced pancreatic cancer growth and therapeutic resist… DOI 10.1016/j.canlet.2023.216457↗
- Xinjian Liu · 2 shared papers, 2021–2025 · strength 0.35
- Yi Miao · 2 shared papers, 2021–2025 · strength 0.35
- Reaid Hasan · 1 shared paper, 2025 · strength 0.30
- Ernest Ramsay Camp · 1 shared paper, 2025 · strength 0.24
- Olamide Tosin Olaoba · 1 shared paper, 2025 · strength 0.24
- Sherin Shaji · 1 shared paper, 2024 · strength 0.22
- Jing Zhou · 1 shared paper, 2023 · strength 0.18
- Ming Jun Yang · 1 shared paper, 2023 · strength 0.18
- Hao Yuan · 1 shared paper, 2021 · strength 0.11
- Kuirong Jiang · 1 shared paper, 2021 · strength 0.11
- Hao Liu · 1 shared paper, 2019 · strength 0.11
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.